Steph & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
10
-10
-50% -$10.2K ﹤0.01% 254
2026
Q1
$18.4K Sell
20
-9
-31% -$9.12K 0.01% 252
2025
Q4
$31.2K Sell
29
-10
-26% -$9.56K 0.01% 229
2025
Q3
$29.8K Buy
39
+29
+290% +$21.6K 0.01% 225
2025
Q2
$7.79K Hold
10
﹤0.01% 280
2025
Q1
$8.26K Hold
10
﹤0.01% 243
2024
Q4
$7.72K Hold
10
﹤0.01% 252
2024
Q3
$8.86K Sell
10
-50
-83% -$45K ﹤0.01% 267
2024
Q2
$54.3K Hold
60
0.02% 174
2024
Q1
$46.7K Hold
60
0.02% 179
2023
Q4
$35K Sell
60
-32
-35% -$18.7K 0.02% 171
2023
Q3
$49.4K Buy
92
+12
+15% +$6.18K 0.03% 172
2023
Q2
$37.5K Sell
80
-20
-20% -$8.39K 0.02% 170
2023
Q1
$34.3K Hold
100
0.02% 170
2022
Q4
$37K Hold
100
0.02% 170
2022
Q3
$32K Hold
100
0.02% 162
2022
Q2
$32K Hold
100
0.02% 162
2022
Q1
$29K Hold
100
0.02% 217
2021
Q4
$28K Hold
100
0.02% 244
2021
Q3
$23K Hold
100
0.01% 220
2021
Q2
$23K Hold
100
0.01% 191
2021
Q1
$19K Hold
100
0.01% 195
2020
Q4
$17K Hold
100
0.01% 201
2020
Q3
$15K Hold
100
0.01% 192
2020
Q2
$16K Hold
100
0.02% 192
2020
Q1
$14K Hold
100
0.02% 194
2019
Q4
$13K Buy
+100
New +$11.6K 0.01% 215

Other funds holding LLY

Steph & Co's LLY Position: Q2 2026 in Review

Steph & Co reduced its Eli Lilly (LLY) stake by 50% in Q2 2026, selling an estimated $10.2K and leaving 10 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Steph & Co first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $54.3K in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steph & Co held 10 shares of Eli Lilly worth $12K as of Q2 2026.
  • Steph & Co sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up ﹤0.01% of Steph & Co's portfolio in Q2 2026, its #254 holding.
  • Steph & Co first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Steph & Co's Eli Lilly position peaked at $54.3K in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.